Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Urologia Internationalis|October 17, 2018
Prediction of Time to Castration-Resistant Prostate Cancer Using Low-Molecular-Weight Protein Tyrosine Phosphatase Expression for Men with Metastatic Hormone-Naïve Prostate CancerYasuhide Miyoshi, Mari Ohtaka, Takashi Kawahara, et al.
BMC Cancer|May 3, 2018
Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxelKoichi Uemura, Yasuhide Miyoshi, Takashi Kawahara, et al.
Anticancer Research|November 14, 2013
Early-onset brain metastases in a breast cancer patient after pathological complete response to neoadjuvant chemotherapyKazuhiro Shimada, Takashi Ishikawa, Shuko Yoneyama, et al.
Lower Urinary Tract Symptoms|March 5, 2025
Retrospective Comparison of Postoperative Outcomes Between Elderly and Non-Elderly Patients With Benign Prostatic Enlargement Using Holmium Laser Enucleation and Transurethral Vaporization of the Prostate at Multiple High-Volume CentersHiroki Ito, Takuma Nirei, Takeshi Fukazawa, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 21, 2020
[A CASE REPORT OF FUNGUS BALL FOUND DURING TRANSURETHRAL URETEROLITHOTOMY]Motoki Sato, Shuko Yoneyama, Masahiro Yanagisawa, et al.
BMC Cancer|February 21, 2016
Prognostic value of the bone scan index using a computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastasesYasuhide Miyoshi, Shuko Yoneyama, Takashi Kawahara, et al.
Biomed Research International|July 28, 2020
Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional StudyTakashi Kawahara, Shuko Yoneyama, Yoshio Ohno, et al.
Japanese Journal of Clinical Oncology|August 19, 2016
Predictors of poor response to secondary alternative antiandrogen therapy with flutamide in metastatic castration-resistant prostate cancerMasato Yasui, Koichi Uemura, Shuko Yoneyama, et al.
Clinical Genitourinary Cancer|January 24, 2017
Prognostic Value of Automated Bone Scan Index in Men With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide or Abiraterone AcetateYasuhide Miyoshi, Koichi Uemura, Takashi Kawahara, et al.
BMC Cancer|March 7, 2023
Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamideTakashi Kawahara, Yusuke Saigusa, Shuko Yoneyama, et al.
Pageof 3